Neurodegenerative Disease Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Neurodegenerative Disease Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Neurodegenerative Disease Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report elaborates the market size, market characteristics, and market growth of the Neurodegenerative Disease industry, and breaks down according to the type, application, and consumption area of Neurodegenerative Disease. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurodegenerative Disease in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Neurodegenerative Disease market covered in Chapter 13:
Amneal Pharmaceuticals Inc.
GlaxoSmithKline Plc
Teva Pharmaceutical
Boehringer Ingelheim Group
AbbVie Inc.
Merck and Co. Inc.
UCB SA
F. Hoffmann-La Roche Ltd
Pfizer Inc.
In Chapter 6, on the basis of types, the Neurodegenerative Disease market from 2015 to 2025 is primarily split into:
N-methyl-D-aspartate Receptor
Selective Serotonin Reuptake Inhibitor
Dopamine Inhibitors
In Chapter 7, on the basis of applications, the Neurodegenerative Disease market from 2015 to 2025 covers:
Hospital
Clinic
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Neurodegenerative Disease Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Neurodegenerative Disease Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Neurodegenerative Disease Market Forces
3.1 Global Neurodegenerative Disease Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Neurodegenerative Disease Market - By Geography
4.1 Global Neurodegenerative Disease Market Value and Market Share by Regions
4.1.1 Global Neurodegenerative Disease Value ($) by Region (2015-2020)
4.1.2 Global Neurodegenerative Disease Value Market Share by Regions (2015-2020)
4.2 Global Neurodegenerative Disease Market Production and Market Share by Major Countries
4.2.1 Global Neurodegenerative Disease Production by Major Countries (2015-2020)
4.2.2 Global Neurodegenerative Disease Production Market Share by Major Countries (2015-2020)
4.3 Global Neurodegenerative Disease Market Consumption and Market Share by Regions
4.3.1 Global Neurodegenerative Disease Consumption by Regions (2015-2020)
4.3.2 Global Neurodegenerative Disease Consumption Market Share by Regions (2015-2020)
5 Neurodegenerative Disease Market - By Trade Statistics
5.1 Global Neurodegenerative Disease Export and Import
5.2 United States Neurodegenerative Disease Export and Import (2015-2020)
5.3 Europe Neurodegenerative Disease Export and Import (2015-2020)
5.4 China Neurodegenerative Disease Export and Import (2015-2020)
5.5 Japan Neurodegenerative Disease Export and Import (2015-2020)
5.6 India Neurodegenerative Disease Export and Import (2015-2020)
5.7
6 Neurodegenerative Disease Market - By Type
6.1 Global Neurodegenerative Disease Production and Market Share by Types (2015-2020)
6.1.1 Global Neurodegenerative Disease Production by Types (2015-2020)
6.1.2 Global Neurodegenerative Disease Production Market Share by Types (2015-2020)
6.2 Global Neurodegenerative Disease Value and Market Share by Types (2015-2020)
6.2.1 Global Neurodegenerative Disease Value by Types (2015-2020)
6.2.2 Global Neurodegenerative Disease Value Market Share by Types (2015-2020)
6.3 Global Neurodegenerative Disease Production, Price and Growth Rate of N-methyl-D-aspartate Receptor (2015-2020)
6.4 Global Neurodegenerative Disease Production, Price and Growth Rate of Selective Serotonin Reuptake Inhibitor (2015-2020)
6.5 Global Neurodegenerative Disease Production, Price and Growth Rate of Dopamine Inhibitors (2015-2020)
7 Neurodegenerative Disease Market - By Application
7.1 Global Neurodegenerative Disease Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Neurodegenerative Disease Consumption by Applications (2015-2020)
7.1.2 Global Neurodegenerative Disease Consumption Market Share by Applications (2015-2020)
7.2 Global Neurodegenerative Disease Consumption and Growth Rate of Hospital (2015-2020)
7.3 Global Neurodegenerative Disease Consumption and Growth Rate of Clinic (2015-2020)
8 North America Neurodegenerative Disease Market
8.1 North America Neurodegenerative Disease Market Size
8.2 United States Neurodegenerative Disease Market Size
8.3 Canada Neurodegenerative Disease Market Size
8.4 Mexico Neurodegenerative Disease Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Neurodegenerative Disease Market Analysis
9.1 Europe Neurodegenerative Disease Market Size
9.2 Germany Neurodegenerative Disease Market Size
9.3 United Kingdom Neurodegenerative Disease Market Size
9.4 France Neurodegenerative Disease Market Size
9.5 Italy Neurodegenerative Disease Market Size
9.6 Spain Neurodegenerative Disease Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Neurodegenerative Disease Market Analysis
10.1 Asia-Pacific Neurodegenerative Disease Market Size
10.2 China Neurodegenerative Disease Market Size
10.3 Japan Neurodegenerative Disease Market Size
10.4 South Korea Neurodegenerative Disease Market Size
10.5 Southeast Asia Neurodegenerative Disease Market Size
10.6 India Neurodegenerative Disease Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Neurodegenerative Disease Market Analysis
11.1 Middle East and Africa Neurodegenerative Disease Market Size
11.2 Saudi Arabia Neurodegenerative Disease Market Size
11.3 UAE Neurodegenerative Disease Market Size
11.4 South Africa Neurodegenerative Disease Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Neurodegenerative Disease Market Analysis
12.1 South America Neurodegenerative Disease Market Size
12.2 Brazil Neurodegenerative Disease Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Amneal Pharmaceuticals Inc.
13.1.1 Amneal Pharmaceuticals Inc. Basic Information
13.1.2 Amneal Pharmaceuticals Inc. Product Profiles, Application and Specification
13.1.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Market Performance (2015-2020)
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Basic Information
13.2.2 GlaxoSmithKline Plc Product Profiles, Application and Specification
13.2.3 GlaxoSmithKline Plc Neurodegenerative Disease Market Performance (2015-2020)
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Basic Information
13.3.2 Teva Pharmaceutical Product Profiles, Application and Specification
13.3.3 Teva Pharmaceutical Neurodegenerative Disease Market Performance (2015-2020)
13.4 Boehringer Ingelheim Group
13.4.1 Boehringer Ingelheim Group Basic Information
13.4.2 Boehringer Ingelheim Group Product Profiles, Application and Specification
13.4.3 Boehringer Ingelheim Group Neurodegenerative Disease Market Performance (2015-2020)
13.5 AbbVie Inc.
13.5.1 AbbVie Inc. Basic Information
13.5.2 AbbVie Inc. Product Profiles, Application and Specification
13.5.3 AbbVie Inc. Neurodegenerative Disease Market Performance (2015-2020)
13.6 Merck and Co. Inc.
13.6.1 Merck and Co. Inc. Basic Information
13.6.2 Merck and Co. Inc. Product Profiles, Application and Specification
13.6.3 Merck and Co. Inc. Neurodegenerative Disease Market Performance (2015-2020)
13.7 UCB SA
13.7.1 UCB SA Basic Information
13.7.2 UCB SA Product Profiles, Application and Specification
13.7.3 UCB SA Neurodegenerative Disease Market Performance (2015-2020)
13.8 F. Hoffmann-La Roche Ltd
13.8.1 F. Hoffmann-La Roche Ltd Basic Information
13.8.2 F. Hoffmann-La Roche Ltd Product Profiles, Application and Specification
13.8.3 F. Hoffmann-La Roche Ltd Neurodegenerative Disease Market Performance (2015-2020)
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Basic Information
13.9.2 Pfizer Inc. Product Profiles, Application and Specification
13.9.3 Pfizer Inc. Neurodegenerative Disease Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Neurodegenerative Disease Market Forecast (2020-2025)
14.2 Europe Neurodegenerative Disease Market Forecast (2020-2025)
14.3 Asia-Pacific Neurodegenerative Disease Market Forecast (2020-2025)
14.4 Middle East and Africa Neurodegenerative Disease Market Forecast (2020-2025)
14.5 South America Neurodegenerative Disease Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Neurodegenerative Disease Market Forecast by Types (2020-2025)
15.1.1 Global Neurodegenerative Disease Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Neurodegenerative Disease Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Neurodegenerative Disease Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Neurodegenerative Disease Picture
Table Neurodegenerative Disease Key Market Segments
Figure Study and Forecasting Years
Figure Global Neurodegenerative Disease Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Neurodegenerative Disease Value ($) and Growth Rate (2015-2020)
Table Global Neurodegenerative Disease Value ($) by Countries (2015-2020)
Table Global Neurodegenerative Disease Value Market Share by Regions (2015-2020)
Figure Global Neurodegenerative Disease Value Market Share by Regions in 2019
Figure Global Neurodegenerative Disease Production and Growth Rate (2015-2020)
Table Global Neurodegenerative Disease Production by Major Countries (2015-2020)
Table Global Neurodegenerative Disease Production Market Share by Major Countries (2015-2020)
Figure Global Neurodegenerative Disease Production Market Share by Regions in 2019
Figure Global Neurodegenerative Disease Consumption and Growth Rate (2015-2020)
Table Global Neurodegenerative Disease Consumption by Regions (2015-2020)
Table Global Neurodegenerative Disease Consumption Market Share by Regions (2015-2020)
Figure Global Neurodegenerative Disease Consumption Market Share by Regions in 2019
Table Global Neurodegenerative Disease Export Top 3 Country 2019
Table Global Neurodegenerative Disease Import Top 3 Country 2019
Table United States Neurodegenerative Disease Export and Import (2015-2020)
Table Europe Neurodegenerative Disease Export and Import (2015-2020)
Table China Neurodegenerative Disease Export and Import (2015-2020)
Table Japan Neurodegenerative Disease Export and Import (2015-2020)
Table India Neurodegenerative Disease Export and Import (2015-2020)
Table Global Neurodegenerative Disease Production by Types (2015-2020)
Table Global Neurodegenerative Disease Production Market Share by Types (2015-2020)
Figure Global Neurodegenerative Disease Production Share by Type (2015-2020)
Table Global Neurodegenerative Disease Value by Types (2015-2020)
Table Global Neurodegenerative Disease Value Market Share by Types (2015-2020)
Figure Global Neurodegenerative Disease Value Share by Type (2015-2020)
Figure Global N-methyl-D-aspartate Receptor Production and Growth Rate (2015-2020)
Figure Global N-methyl-D-aspartate Receptor Price (2015-2020)
Figure Global Selective Serotonin Reuptake Inhibitor Production and Growth Rate (2015-2020)
Figure Global Selective Serotonin Reuptake Inhibitor Price (2015-2020)
Figure Global Dopamine Inhibitors Production and Growth Rate (2015-2020)
Figure Global Dopamine Inhibitors Price (2015-2020)
Table Global Neurodegenerative Disease Consumption by Applications (2015-2020)
Table Global Neurodegenerative Disease Consumption Market Share by Applications (2015-2020)
Figure Global Neurodegenerative Disease Consumption Share by Application (2015-2020)
Figure Global Hospital Consumption and Growth Rate (2015-2020)
Figure Global Clinic Consumption and Growth Rate (2015-2020)
Figure North America Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table North America Neurodegenerative Disease Consumption by Countries (2015-2020)
Table North America Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure North America Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure United States Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Canada Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Mexico Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table Europe Neurodegenerative Disease Consumption by Countries (2015-2020)
Table Europe Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Europe Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Germany Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure France Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Italy Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Spain Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Neurodegenerative Disease Consumption by Countries (2015-2020)
Table Asia-Pacific Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure China Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Japan Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure South Korea Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure India Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Neurodegenerative Disease Consumption by Countries (2015-2020)
Table Middle East and Africa Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure UAE Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure South Africa Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Figure South America Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table South America Neurodegenerative Disease Consumption by Countries (2015-2020)
Table South America Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure South America Neurodegenerative Disease Consumption Market Share by Countries (2015-2020)
Figure Brazil Neurodegenerative Disease Market Consumption and Growth Rate (2015-2020)
Table Amneal Pharmaceuticals Inc. Company Profile
Table Amneal Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Amneal Pharmaceuticals Inc. Production and Growth Rate
Figure Amneal Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table GlaxoSmithKline Plc Company Profile
Table GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline Plc Production and Growth Rate
Figure GlaxoSmithKline Plc Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Company Profile
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Production and Growth Rate
Figure Teva Pharmaceutical Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Group Company Profile
Table Boehringer Ingelheim Group Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Group Production and Growth Rate
Figure Boehringer Ingelheim Group Value ($) Market Share 2015-2020
Table AbbVie Inc. Company Profile
Table AbbVie Inc. Production, Value, Price, Gross Margin 2015-2020
Figure AbbVie Inc. Production and Growth Rate
Figure AbbVie Inc. Value ($) Market Share 2015-2020
Table Merck and Co. Inc. Company Profile
Table Merck and Co. Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Merck and Co. Inc. Production and Growth Rate
Figure Merck and Co. Inc. Value ($) Market Share 2015-2020
Table UCB SA Company Profile
Table UCB SA Production, Value, Price, Gross Margin 2015-2020
Figure UCB SA Production and Growth Rate
Figure UCB SA Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd Company Profile
Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2015-2020
Figure F. Hoffmann-La Roche Ltd Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd Value ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Production by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Production Share by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Value ($) by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Value Share by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Consumption by Applications (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Neurodegenerative Disease Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|